Anti-LILRB4/ILT3/CD85k Antibody (Merck patent anti-ILT3 complex)
Catalog No.
F1830
Anti-LILRB4/ILT3/CD85k Antibody (Merck patent anti-ILT3 complex)
Featured Products
Merck patent anti-ILT3 complex is a CHO-expressed human antibody targeting LILRB4/ILT3/CD85k.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.36 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Merck patent anti-ILT3 complex
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q8NHJ6
Human
Unconjugated
Monoclonal
Protein A
IgG
ELISA, FACS, Kinetics, Functional assay, Animal Model
LILRB4 / ILT3 / CD85k
Please avoid freeze-thaw cycles.